Table 3 Stroke-related hospitalizations, outpatient anticoagulant use and bleeding events among patients hospitalized for stroke in the study period
IMS | MarketScan Commercial | MarketScan Medicare | Optum | Medicaid | |
|---|---|---|---|---|---|
All patients, N | 30,757 | 21,976 | 38,643 | 9,120 | 4,901 |
Patients with stroke-related hospitalizations | |||||
N (%) | 478 (2%) | 146 (1%) | 912 (2%) | 100 (1%) | 40 (1%) |
Hospitalized stroke patients not treated with an anticoagulant in the outpatient setting | |||||
N (%) | 276 (58%) | 92 (63%) | 571 (63%) | 54 (54%) | 20 (50%) |
Patients with bleeding event hospitalization | |||||
N (%) | 222 (1%) | 45 (0%) | 258 (1%) | 43 (0%) | 30 (1%) |
Inpatient hospitalizations | |||||
N (%) | 9,303 (30%) | 4,500 (20%) | 14,271 (37%) | 2,361 (26%) | 1,333 (27%) |
ER visits | |||||
N (%) | 9,342 (30%) | 4,836 (22%) | 13,641 (35%) | 2,311 (25%) | 1,194 (24%) |
Outpatient visits | |||||
N (%) | 27,322 (89%) | 19,983 (91%) | 33,854 (88%) | 8,329 (91%) | 3,805 (78%) |